Literature DB >> 8808442

Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma.

S Shikuwa1, M Ito, M Nakashima, K Hamasaki, S Naito, I Sekine, H Fujii.   

Abstract

We present a rare case of colocalized tumors of hepatocellular carcinoma (HCC) and malignant lymphoma in the liver and bone marrow. A 64-year-old man with hepatitis B virus (HBV)-induced cirrhosis was admitted after detection of elevated serum alpha-fetoprotein level. He was diagnosed as having HCC and treated with chemotherapy and radiotherapy, but the size of the tumors did not diminish. After 11 months' hospitalization, he died due to rupture of esophageal varices. Autopsy revealed two heterogenic malignant tumors, HCC and malignant lymphoma (B cell type), in the liver. These tumors showed colocalization in the liver and bone marrow. The carcinogenetic process of colocalized tumors of HCC and lymphoma was not clarified, but the possibility that persistent HBV infection play a role in promoting hepatocarcinogenic and hematopoietic tumor growths in the reticuloendothelial organs could not be excluded.

Entities:  

Mesh:

Year:  1996        PMID: 8808442     DOI: 10.1007/bf01211200

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  17 in total

1.  HBsAg, chronic lymphoproliferative disorders, and cirrhosis of liver.

Authors:  R Heimann; M B Ray; V J Desmet
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

2.  Development of Hodgkins disease in the course of active chronic hepatitis treated by immunosuppressive drugs.

Authors:  J H Pirotte
Journal:  Am J Gastroenterol       Date:  1974-09       Impact factor: 10.864

3.  The relation of infection with the hepatitis B agent to primary hepatic carcinoma.

Authors:  B S Blumberg; B Larouzé; W T London; B Werner; J E Hesser; I Millman; G Saimot; M Payet
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

4.  Non-Hodgkin's lymphoma presenting as a primary tumor of the liver: presentation, diagnosis and outcome in eight patients.

Authors:  J Y Scoazec; C Degott; N Brousse; J Barge; G Molas; F Potet; J P Benhamou
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

Review 5.  The carcinogenicity of anticancer drugs: a hazard in man.

Authors:  C C Harris
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

6.  Hepatitis B virus infection associated with hematopoietic tumors.

Authors:  E Galun; Y Ilan; N Livni; M Ketzinel; O Nahor; G Pizov; A Nagler; A Eid; A Rivkind; M Laster
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

7.  Primary hepatic malignant lymphoma: its occurrence in a patient with chronic active hepatitis, cirrhosis, and hepatocellular carcinoma associated with hepatitis B viral infection.

Authors:  T S Talamo; A Dekker; J Gurecki; G Singh
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

8.  Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.

Authors:  J Naparstek; M Eliakim
Journal:  Am J Dig Dis       Date:  1978-10

9.  Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.

Authors:  J R Wands; C M Chura; F J Roll; W C Maddrey
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

10.  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

Authors: 
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

View more
  3 in total

1.  Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.

Authors:  Hirotada Tajiri; Keishi Sugimachi; Nao Kinjo; Masahiko Ikebe; Junko Tanaka; Kiyoshi Tanaka; Shuichi Tsukamoto; Shinsuke Mii; Eiji Kajiwara; Tatsuro Shimokama; Hidefumi Higashi
Journal:  Surg Today       Date:  2013-02-13       Impact factor: 2.549

2.  Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.

Authors:  Mu-Hsien Lee; Yu-Ching Lin; Hao-Tsai Cheng; Wen-Yu Chuang; Hsin-Chih Huang; Hsiao-Wen Kao
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

3.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.